Kangji Medical Holdings, also known as Kangji Medical, is a prominent player in the medical device industry, headquartered in China (CN). Founded in 2001, the company has established itself as a leader in the development and manufacturing of advanced medical equipment, particularly in the fields of orthopaedics and surgical instruments. With a strong operational presence across Asia and expanding into international markets, Kangji Medical is renowned for its innovative products, including high-quality implants and surgical tools that enhance patient outcomes. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in healthcare. Kangji Medical's dedication to quality and innovation has earned it a notable reputation, making it a key contributor to the global medical device landscape.
How does Kangji Medical Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kangji Medical Holdings's score of 19 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Kangji Medical Holdings, headquartered in China (CN), reported total carbon emissions of approximately 2,712,360 kg CO2e. This figure includes 127,150 kg CO2e from Scope 1 emissions and 2,585,210 kg CO2e from Scope 2 emissions. The previous year, 2020, the company recorded total emissions of about 2,562,230 kg CO2e, comprising 180,480 kg CO2e from Scope 1 and 2,381,760 kg CO2e from Scope 2. Despite these emissions figures, Kangji Medical Holdings has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. There are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges noted in their reports. The absence of Scope 3 emissions data indicates a potential area for future reporting and improvement. Overall, while Kangji Medical Holdings has made strides in emissions reporting, the lack of defined reduction strategies highlights an opportunity for the company to enhance its climate commitments and align with industry standards for sustainability.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | |
---|---|---|
Scope 1 | 180,480 | 000,000 |
Scope 2 | 2,381,760 | 0,000,000 |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kangji Medical Holdings is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.